Pancreatic Diseases, Robotic Surgical Procedures
Conditions
Brief summary
Pancreatic robotic surgery (PRS) has moved from an almost testimonial procedure to a moment of expansion that is not yet clearly defined. In the pioneering centres, the results achieved are superior to those of open surgery. At present, it is not known how many centres perform CRP, what type of operations they perform, what percentage of the total number of pancreatic operations CRP represents and what results are obtained. The aim of our project is to establish a national multicentre registry of robotic pancreatic surgery that will allow us to answer all these questions. Methodology: This is a one-year prospective multicentre registry involving all general and digestive surgery units in Spain that have a DaVinci robotic platform and wish to participate and perform robotic pancreatectomies. All adult patients undergoing robotic pancreatectomy at participating Spanish centres who meet the inclusion criteria will be included. The registry will be open until 31 March 2026 to include post-operative morbidity and mortality at 90 days. The number of pancreatic surgeries performed in that centre during the same period will be counted to determine the percentage of robotic pancreatic surgery per centre. Intraoperative complications will be measured according to the Satava classification modified by Halls et al. Postoperative complications will be classified according to the Clavien-Dindo classification and the CCI (Comprehensive Complication Index). Pancreatic fistula, postoperative bleeding and delayed gastric emptying were classified according to the ISGPS classification and biliary fistula according to the ISGLS classification.
Interventions
robotic resection with Da Vinci Xi
Sponsors
Study design
Eligibility
Inclusion criteria
* robotic pancreatic resections * Asa I-III * Signed informed consent
Exclusion criteria
* Less than 18 years old. * ASA IV
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative complications | 90 postoperative days | Clavien-Dindo Classification |
| Number of robotic procedures | 1 year | Number of robotic pancreatic procedures |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Experience of each group in robotic pancreatic surgery | 1 year | Questonnaire answering the number of robotic procedures in 2024. |
| Textbook outcome | 1 year | Composite measure: No reintervention, no major complications, no readmission, no pancreatic leak B/C, no mortality and no prolongued hospital stay |
| Total survival | 3 years | survival after surgery in months |
| Disease-free survival | 3 years | Time from surgery to recurrence |